Neuroprotective strategies that limit secondary tissue loss and/or improve functional outcomes have been identified in multiple animal models of ischemic, hemorrhagic, traumatic and nontraumatic cerebral lesions. However, use of these potential interventions in human randomized controlled studies has generally given disappointing results. In this paper, we summarize the current status in terms of neuroprotective strategies, both in the immediate and later stages of acute brain injury in adults. We also review potential new strategies and highlight areas for future research.status: publishe
Neuroprotection remains one of the holy grails of acute ischemic stroke therapy. The ability to prot...
Although a considerable body of scientific data is now available on neuroprotection in acute ischaem...
A 2 days round table has been devoted to a reappraisal of neuroprotection after acute brain injury. ...
Neuroprotective strategies that limit secondary tissue loss and/or improve functional outcomes have ...
Neuroprotective strategies that limit secondary tissue loss and/or improve functional outcomes have ...
Neuroprotective strategies that limit secondary tissue loss and/or improve functional outcomes have ...
Neuroprotective strategies that limit secondary tissue loss and/or improve functional outcomes have ...
Neuroprotective strategies that limit secondary tissue loss and/or improve functional outcomes have ...
Neuroprotective strategies that limit secondary tissue loss and/or improve functional outcomes have ...
Neuroprotective strategies that limit secondary tissue loss and/or improve functional outcomes have ...
Ischemic stroke, intracerebral hemorrhage, subarachnoid hemorrhage, and traumatic brain injury-all h...
Stroke is the leading cause of adult disability and remains the third most common cause of death in ...
Item does not contain fulltextIschemic stroke, intracerebral hemorrhage, subarachnoid hemorrhage, an...
The review discusses the role of neuroprotective therapy in the acute period of ischemic stroke in t...
Stroke is a devastating medical condition, killing millions of people each year and causing serious ...
Neuroprotection remains one of the holy grails of acute ischemic stroke therapy. The ability to prot...
Although a considerable body of scientific data is now available on neuroprotection in acute ischaem...
A 2 days round table has been devoted to a reappraisal of neuroprotection after acute brain injury. ...
Neuroprotective strategies that limit secondary tissue loss and/or improve functional outcomes have ...
Neuroprotective strategies that limit secondary tissue loss and/or improve functional outcomes have ...
Neuroprotective strategies that limit secondary tissue loss and/or improve functional outcomes have ...
Neuroprotective strategies that limit secondary tissue loss and/or improve functional outcomes have ...
Neuroprotective strategies that limit secondary tissue loss and/or improve functional outcomes have ...
Neuroprotective strategies that limit secondary tissue loss and/or improve functional outcomes have ...
Neuroprotective strategies that limit secondary tissue loss and/or improve functional outcomes have ...
Ischemic stroke, intracerebral hemorrhage, subarachnoid hemorrhage, and traumatic brain injury-all h...
Stroke is the leading cause of adult disability and remains the third most common cause of death in ...
Item does not contain fulltextIschemic stroke, intracerebral hemorrhage, subarachnoid hemorrhage, an...
The review discusses the role of neuroprotective therapy in the acute period of ischemic stroke in t...
Stroke is a devastating medical condition, killing millions of people each year and causing serious ...
Neuroprotection remains one of the holy grails of acute ischemic stroke therapy. The ability to prot...
Although a considerable body of scientific data is now available on neuroprotection in acute ischaem...
A 2 days round table has been devoted to a reappraisal of neuroprotection after acute brain injury. ...